drugset / Trial / NCT07059312
A Phase 1 Study of JADE101 in Healthy Participants
RandomizedSequentialDouble-blindBasic science
Summary
This is a Phase 1, first-in-human study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of JADE101 compared to placebo in healthy participants.
Timeline
- Start
- 2025-08-17
- Primary completion
- 2026-10
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JADE101 | Unknown | — | Subcutaneous |
Indications
No indication recorded.